Urinary tract infections (UTIs) are recognized as the second most common medical condition, following respiratory infections. Despite the availability of numerous efficacious antibiotics for the ...

Those who suffer from eye infections that threaten a person’s vision have a new treatment option that is noninvasive and ...

Promising clinical results observed in the first 88 patients evaluated so far, confirming the safety and an important clinical benefit for patients Control of the infection at 3 months for ...

Children undergoing ECMO are at a high risk for nosocomial infection; however, nosocomial infection did not increase ...

The following is a summary of “Global and Regional Burden of Bloodstream Infections Caused by Carbapenem-Resistant ...

P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.

BX-004 is under clinical development by BiomX and currently in Phase II for Resistant Pseudomonas aeruginosa Infections. According to GlobalData, Phase II drugs for Resistant Pseudomonas aeruginosa ...

The Philippines is witnessing a rapid rise in HIV infections, recording a 543% rise in cases between 2010 and 2023. One in three people living with HIV is diagnosed at a late stage, compounding ...

Queen's Infection Prevention & Control (IPAC) Online Professional Development Course is a fully online program with interactive content for health professionals who are new to or are about to enter ...

Reference: “A necrotizing toxin enables Pseudomonas syringae infection across evolutionarily divergent plants” by Kristina Grenz, Khong-Sam Chia, Emma K. Turley, Alexa S. Tyszka, Rebecca E. Atkinson, ...

A necrotizing toxin enables Pseudomonas syringae infection across evolutionarily divergent plants appears in Cell Host and Microbe.